tirzepatide suomi Obesity drug seen as effective for long COVID, gets clinical trial ๐ฅ Tirzepatide is a once-weekly
Description
SURPASS-3 demonstrated superiority over titrated insulin degludec, challenging the conventional diabetes treatment paradigm
Looking at trends over several weeks is usually more helpful than focusing on day-to-day changes
Hayes MR, Borner T, Fortin SM, et al
Current studies suggest tirzepatide does not have a strong link to depression as a direct effect
